Form 8-K - Current report:
SEC Accession No. 0001640334-17-000876
Filing Date
2017-05-08
Accepted
2017-05-08 17:20:14
Documents
5
Period of Report
2017-05-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K artl_8k.htm 8-K 22640
2 EXCLUSIVE LICENSE AGREEMENT artl_ex101.htm EX-10.1 70827
3 FORM OF INDEMNIFICATION AGREEMENT artl_ex102.htm EX-10.2 48946
4 NOTE REPAYMENT AGREEMENT artl_ex103.htm EX-10.3 6538
5 STOCK PURCHASE AGREEMENT artl_ex104.htm EX-10.4 55651
  Complete submission text file 0001640334-17-000876.txt   206098
Mailing Address 29 FITZWILIAM STREET UPPER DUBLIN L2 2
Business Address 29 FITZWILIAM STREET UPPER DUBLIN L2 2 353 1 443 4604
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 800743229 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-199213 | Film No.: 17823486
SIC: 7389 Services-Business Services, NEC